BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 2012085)

  • 1. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.
    Am J Med; 1991 Apr; 90(4):450-9. PubMed ID: 2012085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
    Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events and their association with treatment regimens in the diabetes control and complications trial.
    Diabetes Care; 1995 Nov; 18(11):1415-27. PubMed ID: 8722064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group.
    Diabetes Care; 1988; 11(7):567-73. PubMed ID: 2904881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study.
    Gubitosi-Klug RA; Braffett BH; White NH; Sherwin RS; Service FJ; Lachin JM; Tamborlane WV;
    Diabetes Care; 2017 Aug; 40(8):1010-1016. PubMed ID: 28550194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.
    Diabetes Care; 1987; 10(1):1-19. PubMed ID: 2882967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
    Nathan DM;
    Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
    Genuth S
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group.
    Diabetes Care; 1990 Apr; 13(4):427-33. PubMed ID: 2180661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes; 1997 Feb; 46(2):271-86. PubMed ID: 9000705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    J Pediatr; 1994 Aug; 125(2):177-88. PubMed ID: 8040759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
    ; Orchard TJ; Nathan DM; Zinman B; Cleary P; Brillon D; Backlund JY; Lachin JM
    JAMA; 2015 Jan; 313(1):45-53. PubMed ID: 25562265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).
    ; Nathan DM; Zinman B; Cleary PA; Backlund JY; Genuth S; Miller R; Orchard TJ
    Arch Intern Med; 2009 Jul; 169(14):1307-16. PubMed ID: 19636033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.
    Ann Intern Med; 1996 Feb; 124(4):379-88. PubMed ID: 8554246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic control and hypoglycaemia in the Illawarra area of NSW, Australia: a comparison with the DCCT.
    Moses R; Rodgers D; Griffiths R
    J Qual Clin Pract; 1995 Jun; 15(2):89-97. PubMed ID: 7670722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of a 5-day structured teaching and treatment programme for intensified conventional insulin therapy and risk for severe hypoglycemia.
    Schiel R; Müller UA; Ulbrich S
    Diabetes Res Clin Pract; 1997 Feb; 35(1):41-8. PubMed ID: 9113474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.